Related Articles
Candidate synthetic lethality partners to PARP inhibitors in the treatment of ovarian clear cell cancer (Review)
PARP inhibitors and epithelial ovarian cancer: Molecular mechanisms, clinical development and future prospective (Review)
Clinical benefits of metformin in gynecologic oncology (Review)
CELL-MEDIATED-IMMUNITY AND IMMUNOTHERAPY IN OVARIAN-CANCER (REVIEW)
Transitional cell carcinoma of the ovary (Review)